✅ #FIDELITY Analysis: finerenone reduces the risk of #CV and renal outcomes compared to placebo in patients with type 2 #diabetes and all stages of kidney disease
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫